|Bid||93.25 x 900|
|Ask||93.68 x 900|
|Day's range||93.13 - 94.80|
|52-week range||62.55 - 101.28|
|Beta (5Y monthly)||0.82|
|PE ratio (TTM)||20.62|
|Earnings date||30 Oct 2020 - 03 Nov 2020|
|Forward dividend & yield||4.72 (5.01%)|
|Ex-dividend date||14 Jul 2020|
|1y target est||106.69|
Investors should consider adding a few large-cap names that are prepared to grow for years to come. These three stocks also pay dividends and provide exposure to three very different and vital industries...
Neurocrine Biosciences' (NASDAQ: NBIX) 30% plunge earlier this year during the coronavirus-fueled market meltdown is practically all but forgotten now. Here's what you need to know about Neurocrine's impressive Q2 update. Neurocrine reported revenue of $302.4 million in the second quarter, a 65% increase from the $183.5 million reported in the prior-year period.
According to data published by the U.S. Social Security Administration (SSA) in December 2019, the median monthly benefit paid out to retired individuals is just $1,503. The SSA estimates that approximately nine out of 10 persons aged 65 and up collect Social Security and anticipates paying more than $1 trillion to roughly 65 million people this year. The good news is, by investing in tried-and-true large-cap stocks, you can supplement your Social Security income and strengthen your financial position during an economic downturn.